Cargando…
Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”
Autores principales: | Abdelazeem, Basel, Abbas, Kirellos Said, Brašić, James Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228947/ https://www.ncbi.nlm.nih.gov/pubmed/35744055 http://dx.doi.org/10.3390/medicina58060793 |
Ejemplares similares
-
Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213
por: Aljabali, Ahmed, et al.
Publicado: (2022) -
Reply to Campbell et al. Comment on “Hogas et al. Salt, Not Always a Cardiovascular Enemy? A Mini-Review and Modern Perspective. Medicina 2022, 58, 1175”
por: Hogas, Mihai, et al.
Publicado: (2022) -
The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Abbas, Kirellos Said, et al.
Publicado: (2022) -
Reply to Çınar et al. Comment on “Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874”
por: Caruntu, Ana, et al.
Publicado: (2022) -
Reply to Vrijdag et al. Comment on “Mankowska et al. Critical Flicker Fusion Frequency: A Narrative Review. Medicina 2021, 57, 1096”
por: Mankowska, Natalia D., et al.
Publicado: (2022)